While LPS administration significantly upregulated the expression of IBA-1 and proinflammatory mediators in the SN, treatment with PLD significantly attenuated these effects, suggesting that PLD suppresses neuroinflammation due to overaction of microglia in a rat model of PD. This evidence concerns the gene GPLD1 and Parkinson disease.